INO 241129 5.00P (INO241129P5000) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

INO241129P5000

Watchlist

0.35
0.000.00%

15min DelayTrading Nov 13 15:47 ET

0.00High0.00Low

Intraday

5D
Daily

News

Trump Nominates Marty Makary For FDA Commissioner
Barron'sNov 22 22:27 ET
Express News | World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern
BenzingaNov 22 12:43 ET
Oppenheimer Maintains Inovio Pharmaceuticals(INO.US) With Buy Rating, Cuts Target Price to $15
Moomoo NewsNov 19 03:36 ET · Ratings
The Analyst Landscape: 4 Takes On Inovio Pharmaceuticals
BenzingaNov 18 15:01 ET
Inovio Pharma Price Target Cut to $5.00/Share From $12.00 by HC Wainwright & Co.
Dow JonesNov 18 11:46 ET · Ratings
Oppenheimer Maintains Outperform on Inovio Pharmaceuticals, Lowers Price Target to $15
BenzingaNov 18 08:55 ET · Ratings

Comments

Jaguar8

Oct 21 21:27

Put alert. PR today on data re HPV. Will present tomorrow full efficacy and safety data. SI 14%.

$Inovio Pharmaceuticals (INO.US)$

Trytosaveabit

Oct 21 07:02

Update

$Inovio Pharmaceuticals (INO.US)$ Reuters· 1 min ago
Inovio Announces New Data at Scientific Conferences for Lead Candidate, Ino-3107, as a Potential Treatment for Rrp

Jakeistheforce

Oct 2 08:38

$Inovio Pharmaceuticals (INO.US)$ $iBio Inc (IBIO.US)$
On Friday, the fear of human-to-human spread grew ever so slightly: The CDC confirmed that four health-care workers in Missouri had fallen sick after caring for a patient who was infected with bird flu.

Jakeistheforce

Oct 1 15:38

$iBio Inc (IBIO.US)$ $Inovio Pharmaceuticals (INO.US)$ Bird flu is growing
https://www.msn.com/en-us/health/other/bird-flu-pandemic-fears-skyrocket-as-us-identifies-first-cases-of-possible-human-to-human-transmission/ar-AA1rwhf5?ocid=BingNewsSerp

Trytosaveabit

Jul 25 15:09

Update

$Inovio Pharmaceuticals (INO.US)$ Reuters· 3 mins ago
Inovio Receives Advanced Therapy Medicinal Product Certificate From European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate Ino-3107